100 (010 01)
Acebutolol Hydrochloride Capsule
Product Images NDC 42291-010
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acebutolol Hydrochloride (NDC 42291-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
F1931f84-figure-01 (Acebutolol HCl Capsules Usp India 1)
F1931f84-figure-02 (Acebutolol HCl Capsules Usp India 2)
This table contains information about the percentage of patients who experienced adverse reactions while taking different medications (Acebutolol, Propranolol, Hydrochlorothiazide, and Placebo) for various body systems including cardiovascular, central nervous system, dermatologic, gastrointestinal, genitourinary, musculoskeletal, respiratory, and special senses. Adverse reactions include symptoms such as chest pain, edema, depression, dizziness, fatigue, headache, insomnia, abnormal dreams, rash, constipation, diarrhea, dyspepsia, flatulence, nausea, micturition frequency, arthralgia, myalgia, cough, dyspnea, rhinitis, and abnormal vision.*
F1931f84-figure-03 (Acebutolol HCl Capsules Usp India 3)
This text appears to be a partial data table which lists a set of parameters and corresponding numerical values. It is not clear what the parameters represent because the table headers are not included in the text. Therefore, the purpose or context of this data cannot be determined.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
